LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that President and CEO Safi Bahcall, Ph.D. is meeting with House leaders to discuss policy initiatives that could support job creation and innovation in the U.S. economy. Synta is among 13 companies that are being highlighted as an example of innovative firms that are being hampered by government in their effort to create American jobs.
